Search
Indivior PLC
INDVAdd to Watchlist
38.300USD
+0.370+0.98%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.79BMarket Cap
22.80P/E TTM
More Details of Indivior PLC Company
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Indivior PLC Info
Ticker SymbolINDV
Company nameIndivior PLC
IPO dateDec 24, 2014
CEOCiaffoni (Joseph J)
Number of employees1030
Security typeOrdinary Share
Fiscal year-endDec 24
Address234 Bath Road
CitySLOUGH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeSL1 4EE
Phone448043791090
Websitehttps://www.indivior.com/en
Ticker SymbolINDV
IPO dateDec 24, 2014
CEOCiaffoni (Joseph J)
Company Executives of Indivior PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
227.92K
-8.15%
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
135.98K
--
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
71.52K
+61.33%
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
27.16K
+24.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
16.04K
+40.63%
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
13.35K
+43.27%
Ms. Kathryn Barbara Hudson
Ms. Kathryn Barbara Hudson
Company Secretary
Company Secretary
--
--
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
227.92K
-8.15%
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
135.98K
--
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
71.52K
+61.33%
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
27.16K
+24.00%
FAQs
Who are the top five shareholders of Indivior PLC?
The top five shareholders of Indivior PLC are: Mr. Christian Heidbreder
How many institutions hold shares of Indivior PLC (INDV)?
As of 2026Q1, 516 institutions hold shares of Indivior PLC, with a combined market value of approximately 123.98M, accounting for 102.46% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -10661085.00.
